ES540375A0 - Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias. - Google Patents

Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.

Info

Publication number
ES540375A0
ES540375A0 ES540375A ES540375A ES540375A0 ES 540375 A0 ES540375 A0 ES 540375A0 ES 540375 A ES540375 A ES 540375A ES 540375 A ES540375 A ES 540375A ES 540375 A0 ES540375 A0 ES 540375A0
Authority
ES
Spain
Prior art keywords
bacteria
effectiveness
preparing
procedure
composition based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES540375A
Other languages
English (en)
Other versions
ES8605375A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmos Yhtyma Oy
Original Assignee
Farmos Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Yhtyma Oy filed Critical Farmos Yhtyma Oy
Publication of ES540375A0 publication Critical patent/ES540375A0/es
Publication of ES8605375A1 publication Critical patent/ES8605375A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
ES540375A 1984-03-01 1985-02-13 Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias. Expired ES8605375A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI840816A FI840816A0 (fi) 1984-03-01 1984-03-01 Bakteriepreparat

Publications (2)

Publication Number Publication Date
ES540375A0 true ES540375A0 (es) 1986-03-16
ES8605375A1 ES8605375A1 (es) 1986-03-16

Family

ID=8518638

Family Applications (1)

Application Number Title Priority Date Filing Date
ES540375A Expired ES8605375A1 (es) 1984-03-01 1985-02-13 Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.

Country Status (10)

Country Link
US (1) US4657762A (es)
EP (1) EP0154478A3 (es)
JP (1) JPH0759516B2 (es)
AU (1) AU581198B2 (es)
CA (1) CA1236400A (es)
DK (1) DK70385A (es)
ES (1) ES8605375A1 (es)
FI (1) FI840816A0 (es)
NO (1) NO165744C (es)
ZA (1) ZA85324B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910024A (en) * 1988-07-05 1990-03-20 Micro Chemical, Inc. Method and apparatus for administering live bacteria as feed additives to livestock and poultry
CA1333564C (en) * 1988-08-02 1994-12-20 Thomas Julius Borody Treatment of gastro-intestinal disorders
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5206015A (en) * 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
GB2233343B (en) * 1989-06-30 1993-07-07 Farmos Oy A bacterial preparation for use in poultry
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5302388A (en) * 1991-11-13 1994-04-12 Wisconsin Alumni Research Foundation Control of campylobacter jejuni colonization
DE69422501T2 (de) * 1993-03-16 2000-06-15 Us Agriculture Kompetitiv verdrängende schleimhautflora
EP0801675B1 (en) * 1994-07-29 2003-04-16 The United States of America, as Represented by the Secretary, Department of Agriculture Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry
US5722342A (en) * 1996-06-28 1998-03-03 Us Agriculure Ovo antibiotic and microbial treatment to dimenish salmonellae populations in avians
US5807546A (en) * 1996-10-11 1998-09-15 The United States Of America As Represented By The Secretary Of Agriculture Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
EP2371373A1 (en) 2005-03-18 2011-10-05 The United States of America as represented by the secretary of Agriculture Bacteriocins and novel bacterial strains
EP2351494A1 (en) 2005-03-18 2011-08-03 The United States of America as represented by the secretary of Agriculture Bacteriocins and novel bacterial strains
EP2593187A4 (en) 2010-07-16 2014-04-09 Univ Arkansas METHODS AND COMPOSITIONS COMPRISING SPORTS-CREATING BACTERIA FOR ENHANCING ANIMAL HEALTH
RU2013109251A (ru) 2010-08-04 2014-09-10 Томас Джулиус БОРОДИ Композиции для трансплантации фекальной флоры и способы их получения и применения и устройства для их доставки
WO2012044984A1 (en) 2010-09-30 2012-04-05 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
CN103561752B (zh) 2011-03-09 2016-04-20 明尼苏达大学评议会 用于移植结肠微生物群的组合物和方法
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
WO2014022572A1 (en) 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
CA2915006C (en) 2013-06-20 2021-07-13 Mars, Incorporated Performance pet food product
WO2016183577A1 (en) 2015-05-14 2016-11-17 Crestovo Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
BR112017024777A2 (pt) 2015-05-22 2018-08-07 Univ Arizona State uso de uma composiçao farmacêutica e de um antibiótico não absorvível para tratamento de transtorno do espectro autista referência cruzada a pedidos relacionados?
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
AU2018250206A1 (en) 2017-04-05 2019-10-31 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (PD) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CN110996917A (zh) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953609A (en) * 1974-02-06 1976-04-27 Microlife Technics, Inc. Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
US4030978A (en) * 1976-07-29 1977-06-21 Becton, Dickinson And Company Novel assembly, compositions and methods
JPS54143585A (en) * 1978-04-28 1979-11-08 Kyowa Hakko Kogyo Co Ltd Culturing of microbials and storing of freeze-dried microbial cells
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4251509A (en) * 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration

Also Published As

Publication number Publication date
DK70385D0 (da) 1985-02-15
JPS60202823A (ja) 1985-10-14
ZA85324B (en) 1985-08-28
NO850817L (no) 1985-09-02
EP0154478A2 (en) 1985-09-11
AU581198B2 (en) 1989-02-16
EP0154478A3 (en) 1987-06-10
FI840816A0 (fi) 1984-03-01
DK70385A (da) 1985-09-02
CA1236400A (en) 1988-05-10
NO165744B (no) 1990-12-27
US4657762A (en) 1987-04-14
JPH0759516B2 (ja) 1995-06-28
NO165744C (no) 1991-04-10
ES8605375A1 (es) 1986-03-16
AU3758085A (en) 1985-09-05

Similar Documents

Publication Publication Date Title
ES540375A0 (es) Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.
ES520128A0 (es) Procedimiento para encapsular un agente biologico quimico.
DE3586959T2 (de) Desinfektionsverfahren sowie zusammensetzung dafuer.
IL80495A0 (en) Microbial compositions,their production and their use for treating soil
ES519559A0 (es) Procedimiento para la obtencion de pirazolooxacinas, pirazolotiacinas y pirazoloquinolinas.
DE10075031I2 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
ES510993A0 (es) "procedimiento y dispositivo para la desnitrificacion del agua".
IT1177079B (it) Procedimento ed impianto per raffreddare palline
ES2016618B3 (es) Composicion pesticida para tratamiento de agua.
AR240975A1 (es) Composicion para tratamiento de plantas
ES522698A0 (es) Procedimiento para la obtencion de abonos minerales de efecto prolongado y homogenico.
DE3063347D1 (en) Polyether polyamines, their salts and their application
BR8503368A (pt) Composicao para inibicao do crescimento de microorganismos e produto absorvente de fluidos corporais
MX162347A (es) Composicion polimerica reforzada y metodo para elaborar la misma
ES2000251B3 (es) Equipo desodorizador para equipos traumatologicos.
MX22229A (es) Composicion polimerica organica reforzada y metodo para elaborar la misma.
ES516312A0 (es) Procedimiento para preparar composiciones termoendurecibles conteniendo enlaces oxazolidona y uretano.
BR8200487A (pt) Metodo e dispositivo para o preparo anaerobio de residuos
BR8700447A (pt) Agente preventivo de endurecimento para fertilizante
EG16414A (en) Method and arrangement for the anaerobic biological denitrifiation of aquarium water
ES502079A0 (es) Metodo de preparar unidades cagiformes de crecimiento para organismos vegetales y similares.
NZ221106A (en) Imidazolyl- and 1,2,4-triazolyl- dioxanes and dioxolanes and use as plant fungicides
EG19241A (en) Oximino ether compounds and their use as herbicides.
ES542206A0 (es) Procedimiento para la preparacion de un agente anticorrosivo y lubrificante, a base de araquilsofanato calcico.
JPS57205423A (en) Polyether, manufacture and use as lubricating agent

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051129